Stella Tommasi, PhD

Associate Professor of Research Population and Public Health Sciences

Image of Stella Tommasi, PhD
Is this your profile? Click to edit

Overview

I am an Associate Professor of Research in the Department of Population and Public Health Sciences (PPHS) and a Full Member of the USC Norris Comprehensive Cancer Center (NCCC), Genomic and Epigenomic Regulation Program (GER). Research in my laboratory focuses on investigating the molecular mechanisms underlying the development of cancer and other chronic diseases. Specifically, we aim to elucidate how the genome and epigenome are affected by lifestyle (e.g., smoking, vaping, diet) and environmental exposures (e.g., air pollutants, chemical contaminants). Using a combination of novel seq-based omics technologies, classic molecular biology assays, and bioinformatics tools, my group investigates the role played by tobacco toxicants/carcinogens (and environmental pollutants) in the pathogenesis of cancer and nonalcoholic fatty liver disease (NAFLD), a primary form of liver disease and a growing global epidemic. Characterizing the interaction of genetic, epigenetic, and environmental determinants can provide insights into the complexity and heterogeneity of cancer and NAFLD. Improving our mechanistic understanding of their etiology will be instrumental in developing effective strategies for the prevention, early detection, treatment and monitoring of these diseases.

Research Funding

  • Does secondhand smoke induce epigenetic changes?
    University of California Tobacco Related Disease Research Program (TRDRP) · Aug 1, 2020 – Jul 31, 2021 · Role: Principal Investigator
  • Does secondhand smoke induce epigenetic changes?
    University of California Tobacco Related Disease Research Program (TRDRP) · Aug 1, 2017 – Jul 31, 2020 · Role: Principal Investigator
  • Investigating the carcinogenicity of e-cig
    University of California Tobacco Related Disease Research Program (TRDRP) · Jul 1, 2016 – Jun 30, 2019 · Role: Principal Investigator

Research Keywords

  • Cancer Genetics and Epigenetics
  • Genetic, epigenetic, and environmental determinants of chronic liver disease (NAFLD)
  • Genomic, epigenomic, and transcriptomic effects of vaping versus smoking
  • Environmental epigenetics
  • Role of noncoding RNAs in health and disease

Publications

  • Multidimensional exposure architecture shapes vaping-associated transcriptomic dysregulation in oral epithelium. Front Oncol. 2026; 16:1838256.. View in PubMed
  • Long noncoding RNAs at the crossroads of smoking, oxidative stress, inflammation, and lung disease. Arch Toxicol. 2026 May; 100(5):1789-1823.. View in PubMed
  • Epigenomic Dysregulation in Youth Vapers: Implications for Disease Risk Assessment. Am J Respir Cell Mol Biol. 2025 02; 72(2):206-218.. View in PubMed
  • The interplay of DNA damage and repair, gene expression, and mutagenesis in mammalian cells during oxidative stress. Carcinogenesis. 2024 11 22; 45(11):868-879.. View in PubMed
  • The Untapped Biomarker Potential of MicroRNAs for Health Risk-Benefit Analysis of Vaping vs. Smoking. Cells. 2024 08 10; 13(16).. View in PubMed
  • Exploring the Utility of Long Non-Coding RNAs for Assessing the Health Consequences of Vaping. Int J Mol Sci. 2024 Aug 05; 25(15).. View in PubMed
  • Vaping Dose, Device Type, and E-Liquid Flavor are Determinants of DNA Damage in Electronic Cigarette Users. Nicotine Tob Res. 2023 05 22; 25(6):1145-1154.. View in PubMed
  • DNA Hydroxymethylation in Smoking-Associated Cancers. Int J Mol Sci. 2022 Feb 28; 23(5).. View in PubMed
  • Secondhand smoke affects reproductive functions by altering the mouse testis transcriptome, and leads to select intron retention in Pde1a. Environ Int. 2022 03; 161:107086.. View in PubMed
  • A novel role for vaping in mitochondrial gene dysregulation and inflammation fundamental to disease development. Sci Rep. 2021 11 23; 11(1):22773.. View in PubMed